疤痕子宫阴道试产临床分析

Clinical Analysis of Vaginal Trial Production of Scar Uterine

目的探讨疤痕子宫阴道分娩的可行性。方法选取我院2016年1—12月剖宫产术后疤痕子宫阴道分娩、疤痕子宫择期剖宫产、非疤痕子宫阴道分娩各300例,对比三组分娩结局。结果疤痕子宫再次剖宫产组产后出血量、住院天数、住院费用,均高于疤痕子宫阴道分娩组,差异有统计学意义,P<0.05,新生儿窒息的发生率差异无统计学意义,P>0.05。疤痕子宫阴道分娩与非疤痕子宫经阴道分娩产后出血量、产褥病率、住院天数、住院费用、新生儿窒息的差异无统计学意义,P>0.05。结论剖宫产术后疤痕子宫再次妊娠阴道试产安全、可行。

Objective To discuss the feasibility of vaginal trial production for cesarean scar preanancy. Methods 300 cases of cesarean scar pregnancy, vaginal delivery, scar uterus elective cesarean section, non scar uterus and vaginal delivery in our hospital from January 2016 to December 2016 were selected, the birth outcomes were compared between the three groups. Results The postpartum hemorrhagic volume, days of hospitalization and hospitalization expenses of cesarean section scar uterus elective cesarean delivery group were signifcantly higher than those of scar uterine vaginal delivery group. The difference was statistically significant, P 〈 0.05. Howerver, there was no statistically signifcant difference in the incidence of neonatal asphyxia, P 〉 0.05. There was no statistically significant difference in the incidence of postpartum blood loss, puerperal incidence, hospital stay, hospitalization expenses and neonatal asphyxia between scar uterus vaginal delivery and non scar uterus vaginal delivery, P 〉 0.05. Conclusion After cesarean section, it is safe and feasible to have scar uterus vaginal delivery again.